Key result
Non-sustained ventricular tachycardia (Lown class IV b) was an independent predictor of global mortality and cardiac mortality in hypertensive patients.
Why the study?
Do arrhythmogenic markers, specifically non-sustained ventricular tachycardia, predict mortality in hypertensive patients?
Cohort (n=214)
Do arrhythmogenic markers, specifically non-sustained ventricular tachycardia, predict mortality in hypertensive patients?
Non-sustained ventricular tachycardia is an independent predictor of global and cardiac mortality in hypertensive patients without symptomatic coronary disease or systolic dysfunction.
Answers are grounded in this paper and cite their sources.
Identifies NSVT as a high-risk marker in uncomplicated hypertension; leaves open whether targeted antiarr.
OBJECTIVE: To evaluate the prognostic value of arrhythmogenic markers in hypertensive patients. DESIGN: Two hundred and fourteen hypertensive patients without symptomatic coronary disease, systolic dysfunction, electrolyte disturbances or anti-arrhythmic therapy were included. Recordings were made of 12-lead standard ECGs with calculations of QT interval dispersion, 24 h Holter ECGs (204 patients), echocardiography (187 patients) and signal-averaged ECGs (125 patients). BASELINE DATA: echocardiographic left ventricular hypertrophy was found in 63 patients (33.7%), non-sustained ventricular tachycardia (Lown class IV b) in 33 patients (16.2%), ventricular late potentials in 27 patients (21.6%). Mortality: after a mean follow-up of 42.4 +/- 26.8 months, global mortality was 11.2% (24 patients), cardiac mortality 7.9% (17 patients), sudden death 4.2% (nine patients). Univariate analysis: predictors of global, cardiac and sudden death were age > or = 65 years, ECG strain pattern, Lown class IV b and QT interval dispersion > 80 ms (P < or = 0.01). Left ventricular mass index was closely related to cardiac mortality (P = 0.002). Multivariate analysis: only Lown class IV b was an independent predictor of global (RR 2.6, 95% CI 1.2-6.0) and cardiac mortality (RR 3.5, 95% CI 1.2-9.7). CONCLUSION: In hypertensive patients, non-sustained ventricular tachycardia has a prognostic value.
No takes yet. Share an insight, caveat, or question.
Galinier et al. (1997) conducted a cohort in Systemic hypertension (n=214). Non-sustained ventricular tachycardia (Lown class IV b) was evaluated on Global mortality (RR 2.6, 95% CI 1.2-6.0). Non-sustained ventricular tachycardia (Lown class IV b) was an independent predictor of global mortality and cardiac mortality in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: